课题基金 / 基金详情

Development of minocycline as a neuroimmune therapy for alcohol use disorder

Development of minocycline as a neuroimmune therapy for alcohol use disorder
开发米诺环素作为酒精使用障碍的神经免疫疗法
批准号:
10378321
负责人:
Daniel Roche
金额:
$3.14万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-05-05 至 2022-08-31

项目摘要

项目成果

Daniel Roche的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract This supplement application is in response to the Notice of Special Interest (NOT-OD-20-054): Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars. The PI is in the fourth year of his K01 Mentored Research Scientist Development Award, and his wife gave birth to their first child on 05/18/2020. The PI and his wife have alternated being the sole care providers over the past 10+ months since childbirth. The PI was on official paternity leave until 12/14/20, and his role as sole caregiver until this return date significantly impeded his manuscript and grant productivity, K01 training experiences, and K01 research study progress; all difficulties were further compounded due to the COVID-19 pandemic. The PI is requesting 6 months of research assistant support ($29,092 in direct costs) to support the completion of his delayed K01 research project and to facilitate his return to full productivity post-childbirth.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Development of minocycline as a neuroimmune therapy for alcohol use disorder
  • 批准号:
    10246351
  • 项目类别:
  • 资助金额:
    $17.66万
  • 财政年份:
    2018
  • 负责人:
    Daniel Roche
  • 依托单位:
Development of minocycline as a neuroimmune therapy for alcohol use disorder
Role of estradiol in women smokers' acute HPA axis hormone response to naltrexone
  • 批准号:
    8365275
  • 项目类别:
  • 资助金额:
    $2.29万
  • 财政年份:
    2011
  • 负责人:
    Daniel Roche
  • 依托单位:
Role of estradiol in women smokers' acute HPA axis hormone response to naltrexone
  • 批准号:
    8127350
  • 项目类别:
  • 资助金额:
    $4.18万
  • 财政年份:
    2011
  • 负责人:
    Daniel Roche
  • 依托单位:
海外基金